Fred Alger Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Fred Alger Management, LLC

$19.8 Billion
Q3 2024

A detailed history of Fred Alger Management, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Fred Alger Management, LLC holds 8,821 shares of REGN stock, worth $6.19 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

8,821

Previous 11,123 20.7%

Holding current value

$6.19 Million

Previous $11.7 Million 20.68%

% of portfolio

0.05%

Previous 0.06%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1024.09 - $1201.76 $2.36 Million - $2.77 Million	-2,302 Reduced 20.7%	8,821 $9.27 Million
Q2 2024 Aug 14, 2024	SELL	$883.2 - $1071.19 $32.6 Million - $39.5 Million	-36,878 Reduced 76.83%	11,123 $11.7 Million
Q1 2024 May 15, 2024	SELL	$902.69 - $993.35 $2.34 Million - $2.58 Million	-2,596 Reduced 5.13%	48,001 $46.2 Million
Q4 2023 Feb 14, 2024	SELL	$775.18 - $881.7 $9.55 Million - $10.9 Million	-12,323 Reduced 19.59%	50,597 $44.4 Million
Q3 2023 Nov 14, 2023	BUY	$692.45 - $844.37 $43.5 Million - $53.1 Million	62,836 Added 74804.76%	62,920 $51.8 Million
Q2 2023 Aug 14, 2023	SELL	$700.03 - $830.35 $43.9 Million - $52 Million	-62,665 Reduced 99.87%	84 $60,000
Q1 2023 May 15, 2023	BUY	$680.49 - $826.97 $22.7 Million - $27.6 Million	33,359 Added 113.5%	62,749 $51.6 Million
Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $11.9 Million - $12.9 Million	16,831 Added 134.02%	29,390 $21.2 Million
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $7.21 Million - $9.1 Million	12,559 New	12,559 $8.65 Million
Q4 2020 Feb 16, 2021	SELL	$478.3 - $607.98 $5.05 Million - $6.42 Million	-10,557 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$544.75 - $658.21 $817,125 - $987,315	-1,500 Reduced 12.44%	10,557 $5.91 Million
Q2 2020 Aug 14, 2020	BUY	$493.32 - $643.92 $612,703 - $799,748	1,242 Added 11.48%	12,057 $7.52 Million
Q1 2020 May 15, 2020	BUY	$336.18 - $494.43 $3.64 Million - $5.35 Million	10,815 New	10,815 $5.28 Million
Q3 2019 Nov 14, 2019	SELL	$273.46 - $318.39 $8,477 - $9,870	-31 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$299.6 - $414.82 $24.2 Million - $33.5 Million	-80,712 Reduced 99.96%	31 $10,000
Q1 2019 May 14, 2019	BUY	$372.08 - $439.57 $30 Million - $35.5 Million	80,743 New	80,743 $33.2 Million
Q3 2018 Nov 14, 2018	SELL	$351.14 - $408.51 $351,140 - $408,510	-1,000 Closed	0 $0
Q2 2018 Jul 19, 2018	BUY	$284.6 - $344.99 $284,600 - $344,990	1,000 New	1,000 $345,000
Q4 2017 Feb 14, 2018	SELL	$358.63 - $469.95 $1.43 Million - $1.88 Million	-4,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$431.38 - $504.0 $1.73 Million - $2.02 Million	4,000	4,000 $1.79 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.

Account

Fred Alger Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History